DOP2010000261A - Derivados biciclicos heterociclicos o espirobicicicos heterociclicos enlazados , de pirazolo[1,5-a] pirimidinas, procedimientos para su preparacion y usos de los mismos - Google Patents
Derivados biciclicos heterociclicos o espirobicicicos heterociclicos enlazados , de pirazolo[1,5-a] pirimidinas, procedimientos para su preparacion y usos de los mismosInfo
- Publication number
- DOP2010000261A DOP2010000261A DO2010000261A DO2010000261A DOP2010000261A DO P2010000261 A DOP2010000261 A DO P2010000261A DO 2010000261 A DO2010000261 A DO 2010000261A DO 2010000261 A DO2010000261 A DO 2010000261A DO P2010000261 A DOP2010000261 A DO P2010000261A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- heterociclic
- pirazolo
- pyrimidins
- birds
- procedures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Se describen compuestos de fórmula A: y sales farmacéuticamente aceptables de los mismos, que inhiben selectivamente la actividad Raf quinasa y son útiles para tratar trastornos mediados por Raf quinasas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6784308P | 2008-02-29 | 2008-02-29 | |
US11680908P | 2008-11-21 | 2008-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
DOP2010000261A true DOP2010000261A (es) | 2010-09-15 |
Family
ID=40548843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DO2010000261A DOP2010000261A (es) | 2008-02-29 | 2010-08-27 | Derivados biciclicos heterociclicos o espirobicicicos heterociclicos enlazados , de pirazolo[1,5-a] pirimidinas, procedimientos para su preparacion y usos de los mismos |
Country Status (24)
Country | Link |
---|---|
US (1) | US20100029657A1 (es) |
EP (1) | EP2271649A1 (es) |
JP (1) | JP2011513334A (es) |
KR (1) | KR20100123725A (es) |
CN (1) | CN102083835A (es) |
AP (1) | AP2010005363A0 (es) |
AR (1) | AR070728A1 (es) |
AU (1) | AU2009219175A1 (es) |
BR (1) | BRPI0908403A2 (es) |
CA (1) | CA2716499A1 (es) |
CO (1) | CO6321261A2 (es) |
CR (1) | CR11650A (es) |
DO (1) | DOP2010000261A (es) |
EA (1) | EA201001188A1 (es) |
EC (1) | ECSP10010429A (es) |
IL (1) | IL207576A0 (es) |
MA (1) | MA32110B1 (es) |
MX (1) | MX2010009458A (es) |
NI (1) | NI201000143A (es) |
PE (1) | PE20091833A1 (es) |
SV (1) | SV2010003654A (es) |
TW (1) | TW200951134A (es) |
WO (1) | WO2009108838A1 (es) |
ZA (1) | ZA201005603B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007089031A (ja) | 2005-09-26 | 2007-04-05 | Fuji Xerox Co Ltd | 出力装置 |
WO2007079078A1 (en) | 2005-12-29 | 2007-07-12 | Bayer Schering Pharma Aktiengesellschaft | Diamine derivatives as inhibitors of leukotriene a4 hydrolase |
AU2010332010A1 (en) | 2009-12-14 | 2012-08-02 | Inspire Pharmaceuticals, Inc. | Bridged bicyclic Rho kinase inhibitor compounds, composition and use |
CA2782601C (en) | 2009-12-18 | 2015-07-21 | Mitsubishi Tanabe Pharma Corporation | Novel antiplatelet agent |
EP2402343A1 (en) * | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazole-fused bicyclic compounds |
EP2734520B1 (en) | 2011-07-19 | 2016-09-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
AU2012325909B2 (en) | 2011-10-20 | 2016-06-09 | Glaxosmithkline Llc | Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
EP2768833A4 (en) * | 2011-10-20 | 2015-04-15 | Sirtris Pharmaceuticals Inc | SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS MODULATORS OF SIRTUINS |
US9408885B2 (en) | 2011-12-01 | 2016-08-09 | Vib Vzw | Combinations of therapeutic agents for treating melanoma |
AU2013344716B2 (en) | 2012-11-16 | 2018-03-01 | University Health Network | Pyrazolopyrimidine compounds |
RU2686101C2 (ru) | 2013-03-12 | 2019-04-24 | Селтакссис, Инк. | Способы ингибирования лейкотриен- а4-гидролазы |
WO2014152518A2 (en) | 2013-03-14 | 2014-09-25 | Celtaxsys, Inc. | Inhibitors of leukotriene a4 hydrolase |
BR112015022226A2 (pt) | 2013-03-14 | 2017-07-18 | Celtaxsys Inc | inibidores de leucotrieno a4 hidrolase |
CA2906086A1 (en) | 2013-03-14 | 2014-09-25 | Celtaxsys, Inc. | Inhibitors of leukotriene a4 hydrolase |
EA032255B1 (ru) | 2014-03-27 | 2019-04-30 | Янссен Фармацевтика Нв | ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 4,5,6,7-ТЕТРАГИДРОПИРАЗОЛО[1,5-a]ПИРАЗИНА И ПРОИЗВОДНЫЕ 5,6,7,8-ТЕТРАГИДРО-4H-ПИРАЗОЛО[1,5-a][1,4]ДИАЗЕПИНА В КАЧЕСТВЕ ИНГИБИТОРОВ Ros1 |
EA031639B1 (ru) * | 2014-03-27 | 2019-01-31 | Янссен Фармацевтика Нв | ЗАМЕЩЕННЫЕ 4,5,6,7-ТЕТРАГИДРОПИРАЗОЛО[1,5-а]ПИРИМИДИНОВЫЕ ПРОИЗВОДНЫЕ И 2,3-ДИГИДРО-1H-ИМИДАЗО[1,2-b]ПИРАЗОЛЬНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ ROS1 |
AR100448A1 (es) | 2014-05-21 | 2016-10-05 | Bayer Cropscience Ag | 5-(hetero)aril-piridazinonas y su uso como herbicida |
AU2017319500C1 (en) | 2016-08-31 | 2022-10-20 | Les Laboratoires Servier | Inhibitors of cellular metabolic processes |
EP3579872A1 (en) | 2017-02-10 | 2019-12-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the mapk pathway |
CN112020500A (zh) | 2017-12-22 | 2020-12-01 | 拉文纳制药公司 | 作为磷脂酰肌醇磷酸激酶抑制剂的氨基吡啶衍生物 |
WO2019133810A1 (en) | 2017-12-28 | 2019-07-04 | Tract Pharmaceuticals, Inc. | Stem cell culture systems for columnar epithelial stem cells, and uses related thereto |
US10898484B2 (en) | 2018-05-31 | 2021-01-26 | Celltaxis, Llc | Method of reducing pulmonary exacerbations in respiratory disease patients |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4178449A (en) * | 1978-04-17 | 1979-12-11 | American Cyanamid Company | Pyrazolo[1,5-a]pyrimidines and imidazo-[1,5-a]pyrimidines |
US4236005A (en) * | 1979-07-02 | 1980-11-25 | American Cyanamid Company | Imidazo[1,5-a]pyrimidines |
US4281000A (en) * | 1979-07-09 | 1981-07-28 | American Cyanamid Company | Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents |
US4521422A (en) * | 1983-06-23 | 1985-06-04 | American Cyanamid Company | Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones |
US4900836A (en) * | 1983-06-23 | 1990-02-13 | American Cyanamid Company | (3-amino-1H-pyrazol-4-yl) (aryl)methanones |
US4654347A (en) * | 1983-06-23 | 1987-03-31 | American Cyanamid Company | Aryl and heteroaryl[[7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]methanones |
US4626538A (en) * | 1983-06-23 | 1986-12-02 | American Cyanamid Company | [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
WO2004052315A2 (en) * | 2002-12-11 | 2004-06-24 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
US7176210B2 (en) * | 2003-02-10 | 2007-02-13 | Pfizer Inc. | Cannabinoid receptor ligands and uses thereof |
WO2005089443A2 (en) * | 2004-03-19 | 2005-09-29 | The Penn State Research Foundation | Combinatorial methods and compositions for treatment of melanoma |
WO2007109093A2 (en) * | 2006-03-17 | 2007-09-27 | Wyeth | Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof |
-
2009
- 2009-02-26 US US12/393,565 patent/US20100029657A1/en not_active Abandoned
- 2009-02-27 AU AU2009219175A patent/AU2009219175A1/en not_active Abandoned
- 2009-02-27 AR ARP090100723A patent/AR070728A1/es not_active Application Discontinuation
- 2009-02-27 PE PE2009000313A patent/PE20091833A1/es not_active Application Discontinuation
- 2009-02-27 WO PCT/US2009/035422 patent/WO2009108838A1/en active Application Filing
- 2009-02-27 BR BRPI0908403-7A patent/BRPI0908403A2/pt not_active IP Right Cessation
- 2009-02-27 MX MX2010009458A patent/MX2010009458A/es not_active Application Discontinuation
- 2009-02-27 CA CA2716499A patent/CA2716499A1/en not_active Abandoned
- 2009-02-27 EA EA201001188A patent/EA201001188A1/ru unknown
- 2009-02-27 TW TW098106566A patent/TW200951134A/zh unknown
- 2009-02-27 EP EP09713876A patent/EP2271649A1/en not_active Withdrawn
- 2009-02-27 CN CN2009801153285A patent/CN102083835A/zh active Pending
- 2009-02-27 KR KR1020107020750A patent/KR20100123725A/ko not_active Application Discontinuation
- 2009-02-27 AP AP2010005363A patent/AP2010005363A0/en unknown
- 2009-02-27 JP JP2010548895A patent/JP2011513334A/ja not_active Withdrawn
-
2010
- 2010-08-05 ZA ZA2010/05603A patent/ZA201005603B/en unknown
- 2010-08-12 IL IL207576A patent/IL207576A0/en unknown
- 2010-08-24 CO CO10104173A patent/CO6321261A2/es not_active Application Discontinuation
- 2010-08-25 CR CR11650A patent/CR11650A/es not_active Application Discontinuation
- 2010-08-26 MA MA33124A patent/MA32110B1/fr unknown
- 2010-08-27 DO DO2010000261A patent/DOP2010000261A/es unknown
- 2010-08-27 SV SV2010003654A patent/SV2010003654A/es not_active Application Discontinuation
- 2010-08-27 NI NI201000143A patent/NI201000143A/es unknown
- 2010-08-27 EC EC2010010429A patent/ECSP10010429A/es unknown
Also Published As
Publication number | Publication date |
---|---|
MA32110B1 (fr) | 2011-02-01 |
SV2010003654A (es) | 2011-03-23 |
JP2011513334A (ja) | 2011-04-28 |
EA201001188A1 (ru) | 2011-04-29 |
TW200951134A (en) | 2009-12-16 |
AP2010005363A0 (en) | 2010-08-31 |
AR070728A1 (es) | 2010-04-28 |
AU2009219175A1 (en) | 2009-09-03 |
WO2009108838A8 (en) | 2009-11-12 |
EP2271649A1 (en) | 2011-01-12 |
CA2716499A1 (en) | 2009-09-03 |
MX2010009458A (es) | 2010-09-24 |
CR11650A (es) | 2010-09-14 |
ZA201005603B (en) | 2011-05-25 |
US20100029657A1 (en) | 2010-02-04 |
WO2009108838A1 (en) | 2009-09-03 |
PE20091833A1 (es) | 2009-11-22 |
NI201000143A (es) | 2011-03-09 |
ECSP10010429A (es) | 2010-09-30 |
KR20100123725A (ko) | 2010-11-24 |
CO6321261A2 (es) | 2011-09-20 |
IL207576A0 (en) | 2010-12-30 |
CN102083835A (zh) | 2011-06-01 |
BRPI0908403A2 (pt) | 2015-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2010000261A (es) | Derivados biciclicos heterociclicos o espirobicicicos heterociclicos enlazados , de pirazolo[1,5-a] pirimidinas, procedimientos para su preparacion y usos de los mismos | |
ECSP13012611A (es) | Derivados de pirazol-aminopirimidina como moduladores de la lrrk2 | |
UY29781A1 (es) | Compuestos diazaspiro sustituidos, sales farmacéuticamente aceptables, composiciones farmacéuticas que contienen los compuestos o sales, métodos de preparación y usos | |
CO6620050A2 (es) | Derivados de aminopirimidina como moduladores de la lrrk2 | |
ECSP088210A (es) | Bencimidazoles sustituidos y métodos de preparación | |
DOP2009000141A (es) | Derivados de dihidropiridina de utilidad como inhibidores de la proteína quinasa | |
CO6491058A2 (es) | Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos | |
ECSP088121A (es) | Derivados de pirrolo [2,3-b] piridina comoinhibidores de proteina cinasa | |
BRPI0811617A2 (pt) | derivados de primidina e composições como inibidores de c-kit e pdgfr quinase. | |
CO6321136A2 (es) | Derivados de indazol sustituido por axadiazol para uso como agonistas de esfingosina 1 fosfato (s1p) | |
CU20140023A7 (es) | DERIVADOS DE N-(3-(1,2,4-OXADIAZOL-3/5-IL)FENIL)IMIDAZO[1,2-a]PIRIDIN-3-CARBOXAMIDA COMO INHIBIDORES DE LA QUINASA c-Kit | |
NI201000145A (es) | DERIVADOS DE IMIDAZO - [1, 2-b] - PIRIDAZINA PARA EL TRATAMIENTO DE ENFERMEDAD MEDIADA POR CINASA DE TIROSINA C-MET. | |
EA200901488A1 (ru) | Замещенные имидазолопиридазины, как ингибиторы липидкиназы | |
NI201000137A (es) | Pirrolo [2,3-d] piridinas y usos de las mismas como inhibidores de cinasa de tirosina. | |
NO20085257L (no) | Purinonderivater som HM74a-agonister | |
CO6612228A2 (es) | Inhibidores de jak2 y su uso en el tratamiento de enfermedades mieloproliferativas y cancer | |
UY29469A1 (es) | Compuestos sulfoximino-macrocíclicos y sus sales, composiciones farmacéuticas que comprenden dichos compuestos, métodos de preparación y usos de los mismos. | |
CY1111203T1 (el) | 4-ανιλινοκινολινο-3-καρβοξαμιδια ως αναστολεις κινασης csf-1r | |
EA201500182A1 (ru) | 4-МЕТИЛ-2,3,5,9,9b-ПЕНТААЗАЦИКЛОПЕНТА[a]НАФТАЛИНЫ | |
NO20085099L (no) | Puritonderivativer som HM74A agonister | |
ECSP088925A (es) | Nitrilos espirocíclicos como inhibidores de proteasa | |
BRPI0519709A2 (pt) | derivados de tetralina e indano e usos dos mesmos como antagonistas de 5-ht | |
DOP2011000107A (es) | Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), produccion y uso de los mismos como productos medicinales | |
AR080871A1 (es) | Tieno[3,2-b]piridinas sustituidas como inhibidores de la actividad de la proteina tirosina quinasa | |
UY32055A (es) | Derivados sustituidos de la 5-Halo-N2-[sustituido](1-metil-1H-imidazol-4-il)pirimidin-2,-diamina y sus sales farmacéuticamente aceptables, procesos de preparación, composiciones y aplicaciones. |